I4V-MC-JAHX - ClinicalTrials.gov - NCT03773965
I4V-MC-JAHX - ClinicalTrials.gov - NCT03773965
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed a previous study of baricitinib for the treatment of JIA
Participants must have not developed an allergy to baricitinib
Participants must NOT
Participants must not have permanently stopped baricitinib in the prior study
Trial Summary
Conditions the trial is for
Systemic Juvenile Idiopathic Arthritis
What the trial is testing?
Baricitinib
Could I receive a Placebo?
no
Enrollment Goal
190
Trial Dates
April 2019 - December 2027
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed a previous study of baricitinib for the treatment of JIA
Participants must have not developed an allergy to baricitinib
Participants must NOT
Participants must not have permanently stopped baricitinib in the prior study
Trial Summary
Conditions the trial is for
Systemic Juvenile Idiopathic Arthritis
What the trial is testing?
Baricitinib
Could I receive a Placebo?
no
Enrollment Goal
190
Trial Dates
April 2019 - December 2027
Trial Phase
3
Trial Locations
Hide locations not currently recruiting